Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.54 |
| ▸ | THRB | P10828 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | RAD52 | P43351 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4937876 | 0.92 | TSHR (0.50) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL268727 | 0.90 | THRB (0.65) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL4434329 | 0.85 | TSHR (0.66) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL10424571 | 0.85 | TSHR (0.66) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL2848811 | 0.84 | THRB (0.57) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL13862905 | 0.83 | TSHR (0.53) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL9007734 | 0.82 | THRB (0.58) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL2396556 | 0.82 | THRB (0.48) | TSHRTHRBPOLBAPEX1HTT | |
| Propane SCHEMBL9319279 | 0.82 | TSHR (0.66) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL20712907 | 0.82 | THRB (0.59) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3578375-B1 | MANUFACTURING METHOD OF LAMINATE PRINTED ARTICLE | FUJIFILM CORP (JP) | 2024-07-17 | — | — | EP | disclosed |
| EP-4079818-B1 | ACTIVE ENERGY RAY CURABLE INKJET INK AND ACTIVE ENERGY RAY CURABLE INK SET | TOYO INK SC HOLDINGS CO LTD (JP) | 2024-02-28 | — | — | EP | disclosed |
| US-11898046-B2 | Photopolymerization initiator and producing method thereof, polymerizable composition, ink jet recording method, and acylphosphine oxide compound | FUJIFILM CORPORATION (JP) | 2024-02-13 | — | — | US | disclosed |
| US-11866593-B2 | Ultraviolet curable inkjet ink | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2024-01-09 | — | — | US | disclosed |
| EP-4269112-A1 | ULTRAVIOLET RAY-CURABLE INKJET INK SET AND METHOD FOR PRODUCING PRINTED MATTER | Toyo Ink SC Holdings Co., Ltd. (JP) | 2023-11-01 | — | — | EP | disclosed |
| EP-4269513-A1 | ULTRAVIOLET RADIATION CURING TYPE INKJET INK | Toyo Ink SC Holdings Co., Ltd. (JP) | 2023-11-01 | — | — | EP | disclosed |
| US-11718095-B2 | Flow channel member, liquid ejecting head, liquid ejecting apparatus, and method for manufacturing liquid ejecting apparatus | SEIKO EPSON CORPORATION (JP) | 2023-08-08 | — | — | US | disclosed |
| WO-2023120515-A1 | INKJET COMPOSITION FOR FORMING PARTITION WALL, LED MODULE, METHOD FOR MANUFACTURING LED MODULE, AND INKJET COMPOSITION | 積水化学工業株式会社 | 2023-06-29 | — | — | WO | disclosed |
| US-11685145-B2 | Flow path structure, liquid ejecting apparatus, liquid ejecting head, and method of manufacturing flow path structure | SEIKO EPSON CORPORATION (JP) | 2023-06-27 | — | — | US | disclosed |
| US-11680179-B2 | Ultraviolet curable inkjet ink set and production method of printed matter | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2023-06-20 | — | — | US | disclosed |
| EP-1493757-A1 | PHOTOPOLYMERIZABLE COMPOSITION | Kyowa Hakko Chemical Co., Ltd. (JP) | 2005-01-05 | — | — | EP | disclosed |
| EP-1489460-A2 | Light-sensitive sheet comprising support, first light-sensitive layer and second light-sensitive layer | Fuji Photo Film Co., Ltd. (JP) | 2004-12-22 | — | — | EP | disclosed |
| US-20040222549-A1 | Process for producing three-dimensional model, and three-dimensional model | FUJI PHOTO FILM CO., LTD. | 2004-11-11 | — | — | US | disclosed |
| EP-1475221-A2 | Process for producing three-dimensional model | Fuji Photo Film Co., Ltd. (JP) | 2004-11-10 | — | — | EP | disclosed |
| EP-1475220-A2 | Process for producing three-dimensional model, and three-dimensional model | Fuji Photo Film Co., Ltd. (JP) | 2004-11-10 | — | — | EP | disclosed |
| US-20040188887-A1 | Process of producing three-dimensionally shaped object | FUJI PHOTO FILM CO., LTD. | 2004-09-30 | — | — | US | disclosed |
| US-20040137334-A1 | Volume hologram recording photosensitive composition, volume hologram recording photosensitive medium and volume hologram | DAI NIPPON PRINTING CO., LTD. (JP) | 2004-07-15 | — | — | US | disclosed |
| US-5916714-A | Preparation of a pixel sheet provided with black matrix | FUJI PHOTO FILM CO., LTD. (JP) | 1999-06-29 | — | — | US | disclosed |
| US-5856050-A | FOR COLOR LIQUID CRYSTAL DISPLAY DEVICE. | FUJI PHOTO FILM CO., LTD. (JP) | 1999-01-05 | — | — | US | disclosed |
| EP-0821275-A2 | The preparation of a pixel sheet provided with black matrix | FUJI PHOTO FILM CO., LTD. (JP) | 1998-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11898046-B2 | Photopolymerization initiator and producing method thereof, polymerizable composition, ink jet recording method, and acylphosphine oxide compound | PIP4K2B, PIK3CA, CDK1 | TSHR 4877/4885THRB 4841/4885POLB 743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.